Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (IS:ANGEN) — Stock Price

TL9.00 TRY
▼ -1.10% today

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (IS:ANGEN) is currently trading at TL9.00 TRY, down 1.10% today. Over the past 52 weeks, shares have ranged between TL9.00 and TL14.70. This page tracks Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's live share price on the IS exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Anatolia Tani ve Biyoteknoloji Urunleri market capitalisation.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's daily closing share price and trading volume on the IS exchange over the past year, giving a clear view of recent price momentum and liquidity.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Income Statement — Revenue, Profit & Earnings by Year

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue TL529.83 Million TL343.92 Million TL268.82 Million TL410.11 Million TL421.56 Million
Cost of Revenue TL195.26 Million TL69.40 Million TL44.51 Million TL51.43 Million TL48.23 Million
Gross Profit TL334.57 Million TL274.51 Million TL224.30 Million TL358.68 Million TL373.33 Million
Research & Development TL3.14 Million TL12.99 Million TL2.79 Million TL967.92K TL1.19 Million
SG&A TL80.10 Million TL77.05 Million TL39.13 Million TL19.26 Million TL14.37 Million
Total Operating Expenses TL512.47 Million TL407.91 Million TL151.88 Million TL101.19 Million TL79.26 Million
Operating Income TL17.37 Million TL-63.99 Million TL116.93 Million TL308.92 Million TL342.30 Million
EBITDA — — TL364.14 Million TL474.23 Million TL363.58 Million
EBIT — — TL136.38 Million TL308.56 Million TL342.30 Million
Interest Expense TL3.26 Million TL4.87 Million TL1.40 Million TL2.07 Million TL2.34 Million
Income Before Tax TL-168.74 Million TL-210.95 Million TL340.32 Million TL462.26 Million TL359.71 Million
Income Tax Expense — — TL4.20 Million TL18.88 Million TL43.93 Million
Net Income TL-218.88 Million TL-197.32 Million TL330.39 Million TL433.33 Million TL293.40 Million

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets TL1.79 Billion TL1.95 Billion TL856.92 Million TL859.77 Million TL395.76 Million
Total Current Assets TL758.17 Million TL1.05 Billion TL625.06 Million TL708.03 Million TL316.24 Million
Cash & Equivalents — — — — —
Short-term Investments TL16.29 Million TL84.27 Million TL101.09 Million TL51.88 Million —
Net Receivables TL107.38 Million TL112.51 Million TL87.11 Million TL99.03 Million TL114.94 Million
Inventory TL360.98 Million TL326.43 Million TL90.85 Million TL64.91 Million TL45.60 Million
Property, Plant & Equipment — — TL187.43 Million TL128.77 Million TL64.52 Million
Goodwill — — — — —
Total Liabilities TL235.37 Million TL201.96 Million TL40.51 Million TL33.98 Million TL59.74 Million
Total Current Liabilities TL87.54 Million TL67.11 Million TL18.42 Million TL28.00 Million TL54.87 Million
Long-term Debt — TL0.00 TL294.08K TL1.28 Million TL4.32 Million
Net Debt — — — — —
Total Stockholder Equity TL1.55 Billion TL1.75 Billion TL816.40 Million TL766.74 Million TL309.90 Million
Retained Earnings TL-338.61 Million TL-119.74 Million TL457.47 Million TL432.64 Million TL293.65 Million

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow TL141.41 Million TL424.36 Million TL311.02 Million TL407.20 Million TL235.47 Million
Capital Expenditures TL246.49 Million TL167.05 Million TL94.11 Million TL77.43 Million TL69.59 Million
Free Cash Flow TL-105.08 Million TL257.31 Million TL216.91 Million TL312.84 Million TL235.47 Million
Investing Cash Flow — — TL-140.00 Million TL-67.43 Million TL-67.47 Million
Financing Cash Flow — — TL-309.99 Million TL-12.84 Million TL-34.88 Million
Dividends Paid — TL266.13 Million TL305.56 Million TL210.00 Million TL1.53 Million
Stock-Based Compensation — — — — —
Depreciation TL109.51 Million TL86.45 Million TL22.43 Million TL9.90 Million TL5.46 Million
Change in Cash TL-96.71 Million TL37.17 Million TL-138.97 Million TL326.93 Million TL133.12 Million

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Earnings History — EPS Actual vs. Analyst Estimates

Track Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Sep 30, 2025 -0.35 — —
Jun 30, 2025 -0.41 — —
Mar 31, 2025 -0.48 — —
Dec 31, 2024 -0.14 — —
Sep 30, 2024 -0.32 — —
Jun 30, 2024 -0.19 — —
Mar 31, 2024 -0.27 — —
Dec 31, 2023 -1.07 — —